Loading…
Attending this event?
avatar for Ben Adams

Ben Adams

Fierce Biotech
Senior Editor
avatar for Querida Anderson

Querida Anderson

Fierce Biotech & Fierce Pharma
Managing Editor
avatar for Annalee Armstrong

Annalee Armstrong

Fierce Biotech
Senior Editor
avatar for Eric Crombez

Eric Crombez

Ultragenyx Gene Therapy
Chief Medical Officer
avatar for Kevin Dunleavy

Kevin Dunleavy

Fierce Pharma
Staff Writer
avatar for Colleen Floreck, MS

Colleen Floreck, MS

Catalent Cell & Gene Therapy
Vice President, Marketing and Strategy
avatar for Mike Fraser

Mike Fraser

Novartis Gene Therapies
General Manager of Europe, Middle East and Africa
avatar for Maya Fuerstenau-Sharp

Maya Fuerstenau-Sharp

Sartorius
Head of Marketing Advanced Therapies
avatar for Bobby Gaspar

Bobby Gaspar

Orchard Therapeutics
CEO and Co-Founder
avatar for Ying Huang, PhD

Ying Huang, PhD

Legend Biotech
CEO & CFO
avatar for Jerry Keybl, Ph.D.

Jerry Keybl, Ph.D.

MilliporeSigma
Head of Cell and Gene Therapy Manufacturing
avatar for Kyle LaHucik

Kyle LaHucik

Fierce Biotech
Staff Writer
avatar for Janet Lynch Lambert

Janet Lynch Lambert

Alliance for Regenerative Medicine
CEO
avatar for John Leonard, M.D.

John Leonard, M.D.

Intellia Therapeutics
President and Chief Executive Officer
avatar for Sheila A. Mikhail, JD, MBA

Sheila A. Mikhail, JD, MBA

Asklepios BioPharmaceutical, Inc.
Chief Executive Officer & Co-Founder
avatar for Robert Pietrusko, PharmD

Robert Pietrusko, PharmD

Vor Biopharma
Chief Regulatory and Quality Officer
avatar for Qasim Rafiq, Ph.D.

Qasim Rafiq, Ph.D.

University College London
Associate Professor in Cell and Gene Therapy Bioprocess Engineering...
avatar for Kim Raineri

Kim Raineri

Avrobio
Chief Manufacturing and Technology Officer
avatar for Eric Sagonowsky

Eric Sagonowsky

Fierce Pharma
Senior Editor
avatar for Curran Simpson

Curran Simpson

Regenxbio
Chief Operations and Technology Officer
avatar for Anthony Ting

Anthony Ting

Bone Therapeutics
Chief Scientific Officer
avatar for Thomas VanCott, Ph.D.

Thomas VanCott, Ph.D.

Catalent Cell and Gene Therapy
VP and Global Head of Product Development
avatar for Rebecca Willumson

Rebecca Willumson

Questex
Publisher, Fierce Biotech, Fierce Pharma and Fierce Healthcare